1 / 8

Daily Equity Report 04 Nov 2019

Bullion Premium is one of our premium services. In this service, we provide 3-5 calls in MCX include mcx commodity tips, MCX Bullions, and Mcx live tips, Mcx tips.<br>http://www.capitalstars.com/bullion-premium-mcx-tips/<br>https://www.youtube.com/watch?v=GlKYauahgHI<br>

Télécharger la présentation

Daily Equity Report 04 Nov 2019

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 04THNOV 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! INDIAN EQUITY BENCHMARK- Market benchmark BSE Sensex rose over 100 points in early trade on Friday led by NIFTY gains in Infosys, HDFC twins and ITC amid positive global cues and sustained foreign fund inflow. The 30-share index CLOSE PREVIOUS was trading 136.83 points, or 0.34 per cent, higher at NIKKEI 40,265.88, and the broader NSE Nifty advanced 33.90 points, or 0.29 per cent, to 11,911.35. ! 2083.48 GLOBAL FACE SECTORIAL INDICES ! CLOSE CHANGE (%) Asian Market- Asian markets finished mixed as of the most recent closing prices. The Shanghai Composite gained 0.99% 12054.15 0.14 and the Hang Seng rose 0.65%. The Nikkei 225 lost 0.33%. S&P CNX 500 9706.60 0.17 ! U.S. Market – North and South American markets finished broadly lower on Thursday with shares in Brazil leading the 4656.65 0.37 6148.45 0.16 region. The Bovespa is down 1.10% while Mexico's IPC is off 0.92% and U.S.'s S&P 500 is lower by 0.30%. 0.99 ! TOP GAINERS European markets- European markets are higher today with shares in Germany leading the region. The DAX is up CLOSE CHANGE (%) 0.40% while London's FTSE 100 is up 0.32% and France's CAC 40 is up 0.28%. ZEEL 308.70 18.46 INFRATEL 202.65 6.88 1379.00 5.01 236.80 3.86 TOP LOSERS CLOSE CHANGE (%) YESBANK -6.11 M&M 590.00 -2.71 2207.00 IOC 142.65 -2.83 Daily Equity Report Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. NIFTY SPOT MARKET MOVERS UPSIDE STRATEGY CLOSE (%) 3.81 154.00 VEDL PIVOT POINTS P 11883 R1 R2 11958 758.25 2.60 TECHM 11733 11808 11849 11924 12033 144.60 2.05 S1-11849 S2-11808 R1-11924 R2-11958 ZEEL 308.70 MARKET MOVERS DOWNSIDE (%) -1.82 GAIL 1449.40 -1.61 1303.00 -2.21 ASIANPAINT 1770.00 -2.19 NET FII 7133.71 DII 5537.37 NSE TOTALS BULLISH PIVOT POINTS P 30305 R1 30548 R3 31077 NIFTY 29533 29919 30162 30691 8 4 BANKNIFTY S1-30162 S2-29919 R1-30548 R2-30691 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report MARKET TALKS ! Dr Reddy's net profit doubles to Rs1, 092cr yoy; stock down ~1% Its revenue stood at Rs4, 800.9cr in Q2FY20 as against Rs3, 797.8cr in the year-ago period. Dr. Reddy's Laboratories registered a net profit of Rs1, Kansai Nerolac Paints registers PAT growth of 59.4% in Q2 ! Kansai Nerolac Paints Limited (KNPL), one of the leading paint companies in India, posted consolidated net profit growth of 59.4% yoy at Rs190.8cr in Q2 September 2019 as against Rs119.7cr in Q2FY19. For the quarter, the company declared the net sale of Rs1,237cr a de-growth of 3.8% over the corresponding quarter of the previous year. 092cr, which was more than two-fold as compared with the corresponding period year ago. Its revenue stood at ! Rs4, 800.9cr in Q2FY20 as against Rs3, 797.8cr in the SML Isuzu sales tank 37.9% yoy in October 2019 the Company sold 829 units in October 2019 vs. 515 in October 2018. year-ago period. Revenues from Global Generics (GG) segment came in at Rs32.8bn with a yoy growth of 7%, primarily driven by Europe, Emerging Markets and India and sequentially declined by 1%. ! SML Isuzu's sales plunged 37.3% yoy in October 2019. The company sold 829 units in October 2019 vs. 515 in October 2018. SML's April-October sales were down 11.8% yoy at 6,945 compared to the year-ago period. SML ISUZU Ltd is currently trading at Rs570.30 down by Rs15.35 or 2.62% from its previous closing of Rs585.65 on the BSE. The scrip opened at Rs596.70 and has touched a high and low of Rs596.70 and Rs566 respectively. So far 27,900 (NSE+BSE) shares were traded on the counter. ! Spark Minda associates with Bajaj Auto to e- vehicle manufacturers ! Global Automotive Component Manufacturer ‘SPARK MINDA GROUP is proud of associating with Bajaj Auto, India’s first major two-wheeler manufacturer to take the plunge into electric mobility. We are proud to supply our products such as Keyless system consisting of electronics steering column lock, Key FOB, Smart ECU, Seat and glove box actuation mechanism and few Die casting components during the recent launch of the legendary Bajaj Chetak with its new glorious avatar of e-Scooter. It strongly reflects the confidence of our OEM partner on us and this motivates us to achieve newer milestones of success. Daily Equity Report Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. NAME OF THE STOCK : SUNPHARMA DATE : 04/11/2019 SEGMENT : CASH CHART TYPE : Candlestick : NSE : NSE EXCHANGE EXCHANGE TECHNICAL INDICATORS USED : VOLUME.MACD, RSI. CHART INVESTMENT ADVICE: CALL CS CALL: - BUY SUNPHARMA CASH NR CMP 437 TGT 449 SL 427 RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF UPWARD MOVEMENT IS THERE. OTHER REASON IF ANY :- OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. CapitalStars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. CapitalStars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

  7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Mcx Tips Financial advisory company Sharemarket company Stock Cash Intraday Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

  8. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

More Related